Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Mar, 22 2025
Jan, 27 2026
Jun, 4 2025
Dec, 17 2025
Mar, 31 2026